Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
8.12
-0.16 (-1.93%)
At close: May 9, 2025, 4:00 PM
8.12
0.00 (0.00%)
After-hours: May 9, 2025, 7:57 PM EDT

Intellia Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
45.5757.8836.2852.1233.0557.99
Upgrade
Revenue Growth (YoY)
-13.37%59.55%-30.40%57.69%-43.01%34.55%
Upgrade
Cost of Revenue
462.89466.31435.07419.98229.81150.41
Upgrade
Gross Profit
-417.32-408.43-398.79-367.86-196.75-92.41
Upgrade
Selling, General & Admin
123.75125.83116.590.3171.144.17
Upgrade
Operating Expenses
123.75125.83116.590.3171.144.17
Upgrade
Operating Income
-541.07-534.26-515.29-458.16-267.85-136.58
Upgrade
Interest & Investment Income
43.7847.8149.838.541.282.35
Upgrade
Earnings From Equity Investments
---15.63-11.08-1.33-
Upgrade
EBT Excluding Unusual Items
-497.29-486.46-481.09-460.7-267.89-134.23
Upgrade
Gain (Loss) on Sale of Investments
-28.63-32.57----
Upgrade
Other Unusual Items
---0.1-13.49--
Upgrade
Pretax Income
-525.91-519.02-481.19-474.19-267.89-134.23
Upgrade
Net Income
-525.91-519.02-481.19-474.19-267.89-134.23
Upgrade
Net Income to Common
-525.91-519.02-481.19-474.19-267.89-134.23
Upgrade
Shares Outstanding (Basic)
1019989777156
Upgrade
Shares Outstanding (Diluted)
1019989777156
Upgrade
Shares Change (YoY)
11.19%11.35%15.33%8.57%26.63%18.50%
Upgrade
EPS (Basic)
-5.21-5.25-5.42-6.16-3.78-2.40
Upgrade
EPS (Diluted)
-5.21-5.25-5.42-6.16-3.78-2.40
Upgrade
Free Cash Flow
-381.16-354.66-408.07-346.85-237.79-53.5
Upgrade
Free Cash Flow Per Share
-3.78-3.59-4.60-4.51-3.35-0.96
Upgrade
Gross Margin
------159.35%
Upgrade
Operating Margin
-1187.36%-923.10%-1420.51%-879.04%-810.37%-235.51%
Upgrade
Profit Margin
-1154.11%-896.77%-1326.51%-909.78%-810.49%-231.46%
Upgrade
Free Cash Flow Margin
-836.43%-612.78%-1124.94%-665.46%-719.41%-92.25%
Upgrade
EBITDA
-530.8-523.98-506.32-450.59-260.96-130.27
Upgrade
EBITDA Margin
------224.63%
Upgrade
D&A For EBITDA
10.2710.298.987.576.896.31
Upgrade
EBIT
-541.07-534.26-515.29-458.16-267.85-136.58
Upgrade
EBIT Margin
------235.51%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q